POXEL (EPA:POXEL) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
POXEL

PRESS RELEASE

published on 11/05/2025 at 11:28, 29 days 19 hours ago

Inside Information / Other news releases
Poxel provides update on draft recovery plan, convenes AGM of shareholders. Plan includes cost reduction, new financing, voting on financial statements. Key partner: IPF Partners

Financial Statements AGM Recovery Plan Poxel IPF Partners
BRIEF

published on 11/05/2025 at 09:03, 29 days 22 hours ago

Poxel's Recovery Plan and December Shareholders Meeting

Capital Increase Judicial Liquidation Shareholder Meeting Poxel Recovery Imeglimin Development
PRESS RELEASE

published on 11/05/2025 at 08:58, 29 days 22 hours ago

Inside Information / Other news releases
Poxel provides update on draft recovery plan and convenes Annual General Meeting of Shareholders. Key objectives include business development, cost reduction, and new financing to ensure long-term viability

Annual General Meeting Shareholders Financing Recovery Plan Poxel
BRIEF

published on 10/31/2025 at 18:57, 1 month 4 days ago

Appointment of Yves Decadt to the Board of Directors of Poxel

Board Of Directors Business Strategy Appointment Poxel Yves Decadt
BRIEF

published on 10/16/2025 at 17:56, 1 month 19 days ago

Poxel: 2024 financial results and receivership proceedings

Financial Results Treasury TWYMEEG® Poxel Judicial Recovery
PRESS RELEASE

published on 10/16/2025 at 17:51, 1 month 19 days ago

Inside Information / News release on accounts, results
Poxel reports financial results for full year 2024, including positive net royalties and governance changes. Updates on operational and financial status provided. Commercial momentum for TWYMEEG® in Japan. Cash position and financing details shared

Financial Results Cash Position Governance Changes TWYMEEG® Poxel
BRIEF

published on 08/08/2025 at 17:50, 3 months 27 days ago

POXEL Begins Judicial Reorganization Proceedings

Metabolic Diseases Euronext Listing Judicial Recovery Steatohepatitis Observation Period
BRIEF

published on 07/29/2025 at 20:21, 4 months 6 days ago

Poxel Initiates Reorganization Amid Financial Struggles

Creditors Reorganization Insolvency Corporate Changes Poxel
PRESS RELEASE

published on 07/29/2025 at 20:16, 4 months 6 days ago

Inside Information / Other news releases
Poxel provides update on negotiations with creditors, announces reorganization proceedings & corporate governance change with trading suspension. Press release details Lyon Court filing for insolvency & governance impact

Governance Creditors Reorganization Trading Suspension Poxel
BRIEF

published on 07/08/2025 at 18:51, 4 months 27 days ago

Information on Poxel's capital and voting rights

Share Capital Voting Rights Actions AMF Poxel

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 38 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE